Form 4: AtriCure Director Regina E. Groves Reports Acquisition of Common Stock

Director Regina E. Groves reports acquisition of 5,401 shares of AtriCure, Inc. common stock through a restricted stock award.

Summary

• Regina E. Groves, a director of AtriCure, Inc., filed a Form 4 to report changes in beneficial ownership.
• On May 19, 2025, Groves acquired 5,401 shares of AtriCure common stock through a restricted stock award under the 2023 Stock Incentive Plan.
• The shares were acquired at a price of $0.
• Following the transaction, Groves directly owns 36,167 shares of AtriCure common stock.
• The restricted stock award will vest upon the one-year anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard regulatory filing. The acquisition of shares by a director is mildly positive, suggesting confidence, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in the corporate world. It provides transparency to investors regarding the holdings of key personnel.

Key Dates

Keywords

AtriCure, Director, Regina E. Groves, Form 4, Beneficial Ownership, Restricted Stock Award, Stock Incentive Plan, Common Stock